Suspected Deficient Activation of Vitamin D in Patients With Secondary Hyperparathyroidism
NCT00754442
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Secondary Hyperparathyroidism
Interventions
DRUG:
Teriparatide
Sponsor
University of Maryland, Baltimore